Share Price and Basic Stock Data
Last Updated: October 15, 2025, 6:17 am
| PEG Ratio | 2.24 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Foseco India Ltd, operating in the chemicals sector, has demonstrated a robust growth trajectory in its revenue streams. The company reported sales of ₹407 Cr in December 2022, which increased to ₹477 Cr by December 2023, marking a growth of approximately 17.2%. For the trailing twelve months (TTM), sales stood at ₹551 Cr, indicating a consistent upward trend. Quarterly sales figures also reflect this momentum, with revenue increasing from ₹100 Cr in June 2022 to ₹123 Cr by September 2023. The company’s ability to manage expenses effectively is noteworthy; expenses rose from ₹85 Cr in June 2022 to ₹107 Cr by September 2023, but the growth in sales outpaced expense increases. This efficiency contributes to the operating profit margin (OPM), which was recorded at 17% for the year ending December 2023, showcasing a healthy operational framework. The company’s focus on organic chemicals positions it strategically within a sector that is projected to grow, further enhancing its revenue potential.
Profitability and Efficiency Metrics
Foseco India has exhibited commendable profitability metrics, reflected in its net profit of ₹73 Cr for the year ending December 2023. This represents a significant increase from the previous year’s net profit of ₹46 Cr, translating to a growth rate of approximately 58.7%. The earnings per share (EPS) also saw a substantial rise, recorded at ₹114.28 for December 2023, up from ₹71.98 the previous year. The company boasts an impressive return on equity (ROE) of 23.3% and a return on capital employed (ROCE) of 31.3%, both indicators of effective capital utilization and operational efficiency. Additionally, the interest coverage ratio stood at a remarkable 1246.69x, suggesting that Foseco operates without any debt, providing a cushion against financial strains. The cash conversion cycle is also noteworthy, recorded at -23 days, indicative of efficient working capital management, allowing the company to convert sales into cash quickly.
Balance Sheet Strength and Financial Ratios
Foseco India maintains a solid balance sheet, characterized by minimal borrowings of only ₹2 Cr against reserves of ₹363 Cr. This strong reserve position enhances financial stability and provides a buffer for future investments. The company’s total assets reached ₹522 Cr by June 2025, reflecting a healthy asset base relative to its liabilities, which stood at ₹420 Cr in December 2023. The current ratio is reported at 2.84, indicating good liquidity to cover short-term obligations. Furthermore, the price-to-book value (P/BV) ratio is noted at 8.52x, suggesting that the market values the company highly in comparison to its book value. While the elevated P/BV ratio may be concerning, it is often indicative of investor confidence in the company’s future growth potential. However, the high market capitalization of ₹3,533 Cr relative to its net operating revenue also raises questions about valuation sustainability within the context of sector averages.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Foseco India Ltd reveals significant promoter commitment, with promoters holding 74.98% of the company’s equity. This level of ownership instills confidence among investors regarding the company’s strategic direction. Institutional investment remains minimal, with foreign institutional investors (FIIs) at 0.15% and domestic institutional investors (DIIs) at 0.59%, indicating a potential area for growth in institutional interest. The public holding, comprising 24.28%, reflects a healthy distribution among individual investors, with the number of shareholders reported at 13,019 as of June 2025. The stability in promoter holding alongside the gradual increase in institutional investment could be a positive signal for future capital inflows. However, the low FII and DII participation might limit the stock’s volatility and liquidity, potentially affecting its attractiveness to larger institutional investors.
Outlook, Risks, and Final Insight
If margins sustain in the current range and revenue growth continues, Foseco India could enhance its profitability further, driven by operational efficiencies and effective cost management. However, potential risks include the volatility in raw material prices typical in the chemicals sector, which could affect profit margins. Moreover, the company’s high P/BV ratio may lead to valuation corrections if market sentiments shift. The reliance on domestic markets poses another risk, especially in economic downturns. Conversely, leveraging its strong balance sheet for strategic investments could open new avenues for growth and innovation. Maintaining investor confidence through consistent performance and transparent communication will be key to navigating these challenges. Overall, Foseco India’s strategic positioning and operational efficiencies provide a solid foundation for sustained growth in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Foseco India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 113 Cr. | 318 | 504/255 | 117 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,570 Cr. | 9,548 | 14,300/8,150 | 56.9 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 38.5 Cr. | 128 | 329/114 | 15.5 | 24.9 | 0.78 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.0 Cr. | 35.8 | 35.8/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| Archit Organosys Ltd | 93.7 Cr. | 45.7 | 51.4/34.2 | 15.4 | 33.7 | 1.09 % | 10.8 % | 7.62 % | 10.0 |
| Industry Average | 4,748.85 Cr | 1,748.35 | 432.23 | 340.62 | 0.39% | 14.38% | 10.33% | 7.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 103 | 106 | 111 | 121 | 123 | 122 | 123 | 125 | 141 | 136 | 149 | 157 |
| Expenses | 85 | 88 | 88 | 95 | 103 | 107 | 103 | 103 | 101 | 117 | 114 | 121 | 130 |
| Operating Profit | 14 | 15 | 18 | 15 | 18 | 16 | 20 | 20 | 24 | 24 | 23 | 27 | 27 |
| OPM % | 14% | 15% | 17% | 14% | 15% | 13% | 16% | 16% | 19% | 17% | 17% | 18% | 17% |
| Other Income | 1 | 2 | 2 | 5 | 17 | 7 | 5 | 4 | 4 | 4 | 6 | 4 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 |
| Profit before tax | 14 | 15 | 16 | 19 | 33 | 21 | 22 | 21 | 25 | 26 | 26 | 29 | 29 |
| Tax % | 26% | 26% | 25% | 26% | 17% | 29% | 25% | 25% | 26% | 26% | 26% | 26% | 26% |
| Net Profit | 11 | 11 | 12 | 14 | 28 | 15 | 16 | 16 | 18 | 19 | 20 | 22 | 22 |
| EPS in Rs | 16.53 | 17.11 | 19.20 | 22.30 | 43.31 | 23.13 | 25.54 | 24.82 | 28.97 | 29.95 | 30.61 | 33.93 | 33.71 |
Last Updated: August 1, 2025, 9:20 pm
Below is a detailed analysis of the quarterly data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 8.00 Cr..
- For Expenses, as of Jun 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 121.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 17.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 33.71. The value appears to be declining and may need further review. It has decreased from 33.93 (Mar 2025) to 33.71, marking a decrease of 0.22.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:20 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 227 | 263 | 292 | 340 | 358 | 362 | 323 | 251 | 338 | 407 | 477 | 525 | 583 |
| Expenses | 196 | 224 | 241 | 285 | 306 | 312 | 276 | 230 | 294 | 343 | 408 | 434 | 482 |
| Operating Profit | 31 | 39 | 51 | 55 | 51 | 51 | 46 | 21 | 44 | 63 | 70 | 91 | 101 |
| OPM % | 13% | 15% | 17% | 16% | 14% | 14% | 14% | 8% | 13% | 16% | 15% | 17% | 17% |
| Other Income | 2 | 3 | 2 | 2 | 3 | 4 | 8 | 6 | 6 | 7 | 33 | 18 | 19 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 6 | 9 | 8 | 10 | 10 |
| Profit before tax | 27 | 38 | 48 | 51 | 48 | 50 | 50 | 21 | 43 | 61 | 95 | 98 | 110 |
| Tax % | 34% | 35% | 34% | 36% | 34% | 36% | 30% | 27% | 25% | 25% | 23% | 26% | |
| Net Profit | 18 | 25 | 32 | 33 | 32 | 32 | 35 | 15 | 33 | 46 | 73 | 73 | 82 |
| EPS in Rs | 27.90 | 38.50 | 49.68 | 51.80 | 49.43 | 50.17 | 54.07 | 24.18 | 51.15 | 71.98 | 114.27 | 114.35 | 128.20 |
| Dividend Payout % | 88% | 55% | 53% | 44% | 51% | 50% | 46% | 62% | 49% | 56% | 22% | 22% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 16% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 39% |
| 3 Years: | 52% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | 23% |
| Last Year: | 23% |
Last Updated: September 5, 2025, 4:15 am
Balance Sheet
Last Updated: October 10, 2025, 2:02 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 83 | 91 | 103 | 118 | 139 | 150 | 165 | 176 | 202 | 233 | 280 | 337 | 363 |
| Borrowings | 8 | 6 | 4 | 2 | 1 | -0 | -0 | -0 | -0 | -0 | 1 | 2 | 2 |
| Other Liabilities | 50 | 48 | 50 | 57 | 75 | 82 | 77 | 80 | 86 | 106 | 132 | 138 | 150 |
| Total Liabilities | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
| Fixed Assets | 28 | 26 | 26 | 26 | 23 | 20 | 34 | 31 | 35 | 31 | 39 | 45 | 44 |
| CWIP | -0 | 1 | 1 | 0 | 1 | 6 | 2 | 5 | 0 | 1 | 1 | 2 | 1 |
| Investments | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Assets | 119 | 125 | 136 | 157 | 197 | 213 | 213 | 227 | 259 | 313 | 379 | 436 | 476 |
| Total Assets | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
Below is a detailed analysis of the balance sheet data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00 Cr..
- For Reserves, as of Jun 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Dec 2024) to 363.00 Cr., marking an increase of 26.00 Cr..
- For Borrowings, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Dec 2024) to 150.00 Cr., marking an increase of 12.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Dec 2024) to 44.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Other Assets, as of Jun 2025, the value is 476.00 Cr.. The value appears strong and on an upward trend. It has increased from 436.00 Cr. (Dec 2024) to 476.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Jun 2025, the value is 522.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
Notably, the Reserves (363.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 23.00 | 33.00 | 47.00 | 53.00 | 50.00 | 51.00 | 46.00 | 21.00 | 44.00 | 63.00 | 69.00 | 89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 101 | 113 | 107 | 103 | 88 | 82 | 94 | 80 | 76 | 78 | 84 |
| Inventory Days | 32 | 32 | 35 | 35 | 29 | 36 | 39 | 32 | 43 | 32 | 46 | 47 |
| Days Payable | 86 | 73 | 80 | 81 | 109 | 111 | 130 | 173 | 136 | 146 | 160 | 155 |
| Cash Conversion Cycle | 49 | 60 | 68 | 61 | 23 | 12 | -8 | -46 | -13 | -37 | -36 | -23 |
| Working Capital Days | 49 | 56 | 72 | 70 | 45 | 31 | 20 | 3 | 21 | 11 | 9 | 24 |
| ROCE % | 29% | 38% | 45% | 44% | 36% | 33% | 30% | 12% | 22% | 28% | 32% | 31% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| Diluted EPS (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| Cash EPS (Rs.) | 126.48 | 85.92 | 60.36 | 33.42 | 60.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 448.78 | 374.25 | 326.73 | 285.99 | 268.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 448.78 | 374.25 | 326.73 | 285.99 | 268.36 |
| Dividend / Share (Rs.) | 25.00 | 40.00 | 25.00 | 15.00 | 15.00 |
| Revenue From Operations / Share (Rs.) | 747.53 | 636.87 | 529.26 | 393.25 | 505.01 |
| PBDIT / Share (Rs.) | 142.70 | 109.97 | 77.04 | 42.28 | 84.28 |
| PBIT / Share (Rs.) | 130.50 | 96.03 | 67.83 | 33.02 | 77.71 |
| PBT / Share (Rs.) | 148.99 | 96.03 | 67.83 | 33.02 | 77.71 |
| Net Profit / Share (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| PBDIT Margin (%) | 19.08 | 17.26 | 14.55 | 10.75 | 16.68 |
| PBIT Margin (%) | 17.45 | 15.07 | 12.81 | 8.39 | 15.38 |
| PBT Margin (%) | 19.93 | 15.07 | 12.81 | 8.39 | 15.38 |
| Net Profit Margin (%) | 15.28 | 11.30 | 9.66 | 6.14 | 10.70 |
| Return on Networth / Equity (%) | 25.46 | 19.23 | 15.65 | 8.45 | 20.14 |
| Return on Capital Employeed (%) | 28.89 | 25.55 | 20.70 | 11.50 | 28.82 |
| Return On Assets (%) | 17.39 | 13.31 | 11.09 | 5.86 | 13.88 |
| Asset Turnover Ratio (%) | 1.25 | 1.27 | 1.21 | 0.98 | 1.32 |
| Current Ratio (X) | 2.84 | 2.91 | 2.98 | 2.74 | 2.70 |
| Quick Ratio (X) | 2.59 | 2.72 | 2.72 | 2.58 | 2.44 |
| Inventory Turnover Ratio (X) | 9.37 | 10.15 | 10.47 | 8.17 | 8.90 |
| Dividend Payout Ratio (NP) (%) | 35.00 | 34.73 | 19.54 | 20.68 | 46.23 |
| Dividend Payout Ratio (CP) (%) | 31.62 | 29.09 | 16.56 | 14.95 | 41.22 |
| Earning Retention Ratio (%) | 65.00 | 65.27 | 80.46 | 79.32 | 53.77 |
| Cash Earning Retention Ratio (%) | 68.38 | 70.91 | 83.44 | 85.05 | 58.78 |
| Interest Coverage Ratio (X) | 1246.69 | 0.00 | 0.00 | 38571.14 | 41404.69 |
| Interest Coverage Ratio (Post Tax) (X) | 836.82 | 0.00 | 0.00 | 22053.57 | 26564.77 |
| Enterprise Value (Cr.) | 2210.85 | 1039.64 | 758.83 | 700.49 | 722.16 |
| EV / Net Operating Revenue (X) | 4.63 | 2.56 | 2.24 | 2.79 | 2.24 |
| EV / EBITDA (X) | 24.26 | 14.80 | 15.42 | 25.94 | 13.42 |
| MarketCap / Net Operating Revenue (X) | 5.11 | 3.02 | 2.69 | 3.33 | 2.59 |
| Retention Ratios (%) | 64.99 | 65.26 | 80.45 | 79.31 | 53.76 |
| Price / BV (X) | 8.52 | 5.14 | 4.35 | 4.59 | 4.87 |
| Price / Net Operating Revenue (X) | 5.11 | 3.02 | 2.69 | 3.33 | 2.59 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.01 | 0.04 |
After reviewing the key financial ratios for Foseco India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For Diluted EPS (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For Cash EPS (Rs.), as of Dec 23, the value is 126.48. This value is within the healthy range. It has increased from 85.92 (Dec 22) to 126.48, marking an increase of 40.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 448.78. It has increased from 374.25 (Dec 22) to 448.78, marking an increase of 74.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 448.78. It has increased from 374.25 (Dec 22) to 448.78, marking an increase of 74.53.
- For Dividend / Share (Rs.), as of Dec 23, the value is 25.00. This value exceeds the healthy maximum of 3. It has decreased from 40.00 (Dec 22) to 25.00, marking a decrease of 15.00.
- For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 747.53. It has increased from 636.87 (Dec 22) to 747.53, marking an increase of 110.66.
- For PBDIT / Share (Rs.), as of Dec 23, the value is 142.70. This value is within the healthy range. It has increased from 109.97 (Dec 22) to 142.70, marking an increase of 32.73.
- For PBIT / Share (Rs.), as of Dec 23, the value is 130.50. This value is within the healthy range. It has increased from 96.03 (Dec 22) to 130.50, marking an increase of 34.47.
- For PBT / Share (Rs.), as of Dec 23, the value is 148.99. This value is within the healthy range. It has increased from 96.03 (Dec 22) to 148.99, marking an increase of 52.96.
- For Net Profit / Share (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For PBDIT Margin (%), as of Dec 23, the value is 19.08. This value is within the healthy range. It has increased from 17.26 (Dec 22) to 19.08, marking an increase of 1.82.
- For PBIT Margin (%), as of Dec 23, the value is 17.45. This value is within the healthy range. It has increased from 15.07 (Dec 22) to 17.45, marking an increase of 2.38.
- For PBT Margin (%), as of Dec 23, the value is 19.93. This value is within the healthy range. It has increased from 15.07 (Dec 22) to 19.93, marking an increase of 4.86.
- For Net Profit Margin (%), as of Dec 23, the value is 15.28. This value exceeds the healthy maximum of 10. It has increased from 11.30 (Dec 22) to 15.28, marking an increase of 3.98.
- For Return on Networth / Equity (%), as of Dec 23, the value is 25.46. This value is within the healthy range. It has increased from 19.23 (Dec 22) to 25.46, marking an increase of 6.23.
- For Return on Capital Employeed (%), as of Dec 23, the value is 28.89. This value is within the healthy range. It has increased from 25.55 (Dec 22) to 28.89, marking an increase of 3.34.
- For Return On Assets (%), as of Dec 23, the value is 17.39. This value is within the healthy range. It has increased from 13.31 (Dec 22) to 17.39, marking an increase of 4.08.
- For Asset Turnover Ratio (%), as of Dec 23, the value is 1.25. It has decreased from 1.27 (Dec 22) to 1.25, marking a decrease of 0.02.
- For Current Ratio (X), as of Dec 23, the value is 2.84. This value is within the healthy range. It has decreased from 2.91 (Dec 22) to 2.84, marking a decrease of 0.07.
- For Quick Ratio (X), as of Dec 23, the value is 2.59. This value exceeds the healthy maximum of 2. It has decreased from 2.72 (Dec 22) to 2.59, marking a decrease of 0.13.
- For Inventory Turnover Ratio (X), as of Dec 23, the value is 9.37. This value exceeds the healthy maximum of 8. It has decreased from 10.15 (Dec 22) to 9.37, marking a decrease of 0.78.
- For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 35.00. This value is within the healthy range. It has increased from 34.73 (Dec 22) to 35.00, marking an increase of 0.27.
- For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 31.62. This value is within the healthy range. It has increased from 29.09 (Dec 22) to 31.62, marking an increase of 2.53.
- For Earning Retention Ratio (%), as of Dec 23, the value is 65.00. This value is within the healthy range. It has decreased from 65.27 (Dec 22) to 65.00, marking a decrease of 0.27.
- For Cash Earning Retention Ratio (%), as of Dec 23, the value is 68.38. This value is within the healthy range. It has decreased from 70.91 (Dec 22) to 68.38, marking a decrease of 2.53.
- For Interest Coverage Ratio (X), as of Dec 23, the value is 1,246.69. This value is within the healthy range. It has increased from 0.00 (Dec 22) to 1,246.69, marking an increase of 1,246.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 836.82. This value is within the healthy range. It has increased from 0.00 (Dec 22) to 836.82, marking an increase of 836.82.
- For Enterprise Value (Cr.), as of Dec 23, the value is 2,210.85. It has increased from 1,039.64 (Dec 22) to 2,210.85, marking an increase of 1,171.21.
- For EV / Net Operating Revenue (X), as of Dec 23, the value is 4.63. This value exceeds the healthy maximum of 3. It has increased from 2.56 (Dec 22) to 4.63, marking an increase of 2.07.
- For EV / EBITDA (X), as of Dec 23, the value is 24.26. This value exceeds the healthy maximum of 15. It has increased from 14.80 (Dec 22) to 24.26, marking an increase of 9.46.
- For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 5.11. This value exceeds the healthy maximum of 3. It has increased from 3.02 (Dec 22) to 5.11, marking an increase of 2.09.
- For Retention Ratios (%), as of Dec 23, the value is 64.99. This value is within the healthy range. It has decreased from 65.26 (Dec 22) to 64.99, marking a decrease of 0.27.
- For Price / BV (X), as of Dec 23, the value is 8.52. This value exceeds the healthy maximum of 3. It has increased from 5.14 (Dec 22) to 8.52, marking an increase of 3.38.
- For Price / Net Operating Revenue (X), as of Dec 23, the value is 5.11. This value exceeds the healthy maximum of 3. It has increased from 3.02 (Dec 22) to 5.11, marking an increase of 2.09.
- For EarningsYield, as of Dec 23, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Dec 22) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Foseco India Ltd:
- Net Profit Margin: 15.28%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.89% (Industry Average ROCE: 14.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.46% (Industry Average ROE: 10.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 836.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 45.2 (Industry average Stock P/E: 432.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.28%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Gat Nos. 922 & 923, Pune District Maharashtra 412208 | investor.grievance@vesuvius.com http://www.fosecoindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Moti Kirpalani | Chairperson & Director |
| Mr. Prasad Chavare | Managing Director & CEO |
| Mr. Mark Russel Collis | Director |
| Ms. Anita Belani | Director |
| Ms. Karena Cancilleri | Director |
| Mr. Amitabha Mukhopadhyay | Director |
FAQ
What is the intrinsic value of Foseco India Ltd?
Foseco India Ltd's intrinsic value (as of 15 October 2025) is 4899.21 which is 15.38% lower the current market price of 5,790.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,697 Cr. market cap, FY2025-2026 high/low of 6,846/3,205, reserves of ₹363 Cr, and liabilities of 522 Cr.
What is the Market Cap of Foseco India Ltd?
The Market Cap of Foseco India Ltd is 3,697 Cr..
What is the current Stock Price of Foseco India Ltd as on 15 October 2025?
The current stock price of Foseco India Ltd as on 15 October 2025 is 5,790.
What is the High / Low of Foseco India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Foseco India Ltd stocks is 6,846/3,205.
What is the Stock P/E of Foseco India Ltd?
The Stock P/E of Foseco India Ltd is 45.2.
What is the Book Value of Foseco India Ltd?
The Book Value of Foseco India Ltd is 579.
What is the Dividend Yield of Foseco India Ltd?
The Dividend Yield of Foseco India Ltd is 0.43 %.
What is the ROCE of Foseco India Ltd?
The ROCE of Foseco India Ltd is 31.3 %.
What is the ROE of Foseco India Ltd?
The ROE of Foseco India Ltd is 23.3 %.
What is the Face Value of Foseco India Ltd?
The Face Value of Foseco India Ltd is 10.0.